Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zaher Radi

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 22, 2021
Experiments in the EpiDerm 3D Skin In Vitro Model and Minipigs In Vivo Indicate Comparatively Lower In Vivo Skin Sensitivity of Topically Applied Aneugenic CompoundsMaik Schuler, Lindsay Tomlinson, Michael Homiski, et al.
Toxicologic Pathology|March 8, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280586 and rituximab (MabThera®)Anne M Ryan, Sharon A Sokolowski, Chee-Keng Ng, et al.
Regulatory Toxicology and Pharmacology : RTP|April 19, 2021
An orthogonal methods assessment of topical drug concentrations in skin and the impact for risk assessment in the viable epidermisBrett D Hollingshead, Lindsay Tomlinson, Jim Finley, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 22, 2021
Experiments in the EpiDerm 3D Skin In Vitro Model and Minipigs In Vivo Indicate Comparatively Lower In Vivo Skin Sensitivity of Topically Applied Aneugenic CompoundsMaik Schuler, Lindsay Tomlinson, Michael Homiski, et al.
Toxicologic Pathology|March 8, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280586 and rituximab (MabThera®)Anne M Ryan, Sharon A Sokolowski, Chee-Keng Ng, et al.
Regulatory Toxicology and Pharmacology : RTP|April 19, 2021
An orthogonal methods assessment of topical drug concentrations in skin and the impact for risk assessment in the viable epidermisBrett D Hollingshead, Lindsay Tomlinson, Jim Finley, et al.
Pageof 2